Literature DB >> 2994954

The BALB/c mouse as a model to study orthopoxviruses.

R M Buller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2994954     DOI： 10.1007/978-3-642-70740-7_22

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  5 in total

1.  Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses.

Authors:  Daisuke Hayasaka; Francis A Ennis; Masanori Terajima
Journal:  Virol J       Date:  2007-02-27       Impact factor: 4.099

3.  Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains.

Authors:  Jaqueline Maria Siqueira Ferreira; Betânia Paiva Drumond; Maria Isabel Maldonado Coelho Guedes; Marcelo Antônio Pascoal-Xavier; Camila Megale Almeida-Leite; Rosa Maria Esteves Arantes; Bruno Eduardo Fernandes Mota; Jônatas Santos Abrahão; Pedro Augusto Alves; Fernando Meireles Oliveira; Paulo César Peregrino Ferreira; Cláudio Antônio Bonjardim; Zélia Inês Portela Lobato; Erna Geessien Kroon
Journal:  PLoS One       Date:  2008-08-26       Impact factor: 3.240

4.  Ectromelia Virus Disease Characterization in the BALB/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures.

Authors:  Jennifer Garver; Lauren Weber; Eric M Vela; Mike Anderson; Richard Warren; Michael Merchlinsky; Christopher Houchens; James V Rogers
Journal:  Viruses       Date:  2016-07-22       Impact factor: 5.048

5.  Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antiviral Res       Date:  2004-07       Impact factor: 10.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.